Cyfra 21-1 and SCC Ag, Useful Oncomarkers in Head and Neck Cancer
Authors:
- 4 November 2025
- journal article
- research article
- Published by Springer Nature in Bratislava Medical Journal
- Vol. 126 (12) , 3608-3623
Abstract
No abstract availableKeywords
Funding Information
- Univerzita Palackého v Olomouci (IGA LF 2024-15)
- Ministerstvo Zdravotnictví Ceské Republiky ((FNOl, 00098892))
This publication has 38 references indexed in Scilit:
- Clinical relevance of CYFRA 21-1 as a tumour marker in patients with oropharyngeal squamous cell carcinomaEuropean Archives of Oto-Rhino-Laryngology, 2020
- Serum SCCA levels in patients suffering cancers or other diseases2019
- Pretreatment serum CYFRA 21-1 level correlates significantly with survival of cervical cancer patients: A multivariate analysis of 506 casesGynecologic Oncology, 2015
- Clinical significance of preoperative squamous cell carcinoma antigen in oral‐cavity squamous cell carcinomaThe Laryngoscope, 2011
- Detection of serum Cyfra 21-1 in patients with primary oral squamous cell carcinomaInternational Journal of Oral and Maxillofacial Surgery, 2007
- Serum tumor markers in the management of ovarian, endometrial and cervical cancerBiomedicine & Pharmacotherapy, 2004
- Breast Tumours2003
- Serum CYFRA 21-1 is one of the most reliable tumor markers for breast carcinomaCancer, 2000
- Conventional tumor markers are prognostic indicators in patients with head and neck squamous cell carcinomaCancer Letters, 2000
- Cyfra 21-1: A New Potential Tumor Marker for Squamous Cell Carcinoma of Head and NeckJAMA Otolaryngology–Head & Neck Surgery, 1995